Please assess the completion status of the following clinical trial:

Trial Title: Effects of Statin and Ezetimibe Association on Kinetics of Artificial Chilomicrons

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Stable coronary heart disease.~Exclusion Criteria:~* Renal and Liver failure~* Hypothyroidism~* Diabetes mellitus~* Neoplasia~* Heart failure.

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- group1 ezetimibe (Type: EXPERIMENTAL): 6 week wash out, followed by 06 week ezetimibe 10mg once a day e then 6 week ezetimibe 10mg plus sinvastatin 20mg for more 6 week.
- group 2 simvastatin (Type: ACTIVE_COMPARATOR): 6 week simvastatin 20mg once a day followed by 6 week simvastatin 80mg once a day.

Based on this trial design, predict the completion outcome and termination type (if applicable).